Korea's First Pediatric Endotracheal Tube Offers Hope for Airway Stenosis Patients

A doctor at Seoul National University Hospital has created Korea's first endotracheal tube designed specifically for children. The new device aims to improve treatment for young patients with airway stenosis, a condition affecting 100 to 200 children in the country each year. The device was developed to address the limitations of improvised solutions previously used in paediatric cases. Unlike older methods, it closely matches the structure of a child's airway, accounting for differences in tissue and growth by age and weight.

The Ministry of Food and Drug Safety has designated it a 'rare medical device'. This classification cuts the approval review period in half, speeding up its path to clinical use. Safety testing will start this year, with regulatory approval expected in early 2025. Once approved, the device is set to become commercially available by the second quarter of next year. Doctors anticipate it will reduce complications during procedures and increase surgical success rates for children with airway stenosis.

The new endotracheal tube offers a tailored solution for a condition that previously relied on makeshift devices. With faster regulatory processing and planned availability in mid-2025, it is expected to provide safer and more effective treatment for young patients in Korea.